Mohit Manrao, SVP, Head of US Oncology at AstraZeneca, shared on LinkedIn:
“AstraZeneca at ESMO 2026 – 5 Highlights.
At ESMO 2026, we shared data reflecting our commitment to advancing cancer care and improving outcomes for patients.
- Pivotal Studies
- Presidential Presentations
- Tumour Types Featured in Presidential Presentations
- Backbone Medicines
- Oncology Ambition: Eliminating Cancer as a Cause of Death
What an incredible team effort! A huge thank you to ALL of our colleagues who spent months preparing for such a successful congress. It was inspiring to come together with investigators and partners, share our commitment to transforming outcomes, and keep pushing toward a future filled with greater hope for people affected by cancer.”
You can also read: 25 Posts Not to Miss from ESMO Congress 2026: Day 5
